Geller Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 29.3% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,528 shares of the medical equipment provider's stock after selling 1,046 shares during the quarter. Geller Advisors LLC's holdings in Intuitive Surgical were worth $1,242,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical during the second quarter valued at about $26,000. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 35 shares during the last quarter. LGT Financial Advisors LLC increased its stake in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 54 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in Intuitive Surgical in the second quarter valued at approximately $37,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
NASDAQ:ISRG opened at $550.41 on Monday. The company has a 50 day simple moving average of $516.21 and a two-hundred day simple moving average of $474.66. The company has a market cap of $196.05 billion, a PE ratio of 88.49, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a 12 month low of $307.72 and a 12 month high of $556.23.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.
A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Piper Sandler reiterated an "overweight" rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. Finally, Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research note on Monday, October 14th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $541.33.
View Our Latest Analysis on Intuitive Surgical
In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the firm's stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,723 shares of company stock worth $26,241,747. Corporate insiders own 0.80% of the company's stock.
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.